Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Never Touch Sterile Surfaces Without Wearing Gloves

Posted on May 20, 2025 By digi

Never Touch Sterile Surfaces Without Wearing Gloves

Never Touch Sterile Surfaces with Bare Hands

Remember: Gloves must be worn and sanitized before touching any sterile surface—direct hand contact is a major GMP violation.

Why This Matters in GMP

Sterile surfaces are critical points of potential contamination in aseptic processing. Touching them with ungloved or improperly sanitized hands introduces microbial risk and compromises sterility assurance. Human skin carries a high microbial load and is a known contamination vector. Whether it’s a vial stopper, syringe plunger, or laminar airflow hood surface, GMP mandates barrier protection through gloving. This practice is fundamental to cleanroom behavior and hygiene protocol. Failing to wear gloves can lead to product contamination, batch rejections, or infections in patients—especially with injectable products.

Also Read:  Validate Software Used in GMP Data Acquisition Systems

Regulatory and Compliance Implications

FDA 21 CFR Part 211.113 requires control of microbiological contamination. EU GMP Annex 1 mandates sterile gloves for aseptic operations. WHO GMP and Schedule M emphasize use of protective apparel to prevent contamination of sterile zones. Regulatory inspections focus heavily on personnel practices and cleanroom discipline. Observations regarding improper glove usage or direct hand contact with sterile materials are classified as critical violations. Facilities must enforce strict gowning and aseptic behavior protocols with full documentation and training records.

Implementation Best Practices

  • Ensure gloves are donned after gowning and sanitized before every sterile surface contact.
  • Use sterile, powder-free gloves and replace them if damaged or contaminated.
  • Train operators on aseptic techniques, including gloved hand positioning and disinfection.
  • Audit cleanroom operations periodically for compliance with gloving SOPs.
  • Include glove usage verification in media fill validations and operator qualification programs.
Also Read:  The Role of GMP in Preventing Contamination in Drug Development

Regulatory References

  • FDA 21 CFR Part 211.113 – Microbiological Contamination Control
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO GMP – Personal Hygiene and Protective Apparel
  • Schedule M – Sterile Area Garment and Glove Practices
GMP Tips Tags:aseptic processing, aseptic technique, cleanroom behavior, contamination control, EU GMP Annex 1, FDA 21 CFR Part 211, glove usage, GMP compliance, hand hygiene, microbial control, personnel practices, Schedule M, sterile surface handling, WHO GMP

Post navigation

Previous Post: Role of ICH, WHO, and PIC/S in Setting Global GMP Inspection Benchmarks
Next Post: Common Elements Across Global GMP Inspection Systems

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Do Not Leave Batch Records in Uncontrolled Office Areas

    Do Not Leave Batch Records… Read more

GMP Tips

  • Do Not Leave Batch Records in Uncontrolled Office Areas
  • Implement UV Sterilization Protocols in GMP Change Rooms
  • Do Not Allow Incomplete Documentation During GMP Batch Record Review
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Use Damaged Sieves or Mesh During Granulation in GMP
  • Conduct Alarm Challenge Tests to Validate Critical GMP System Responses
  • Do Not Ignore Elevated Noise Levels in GMP Classified Areas
  • Cross-Verify Certificate of Analysis (COA) With Raw Data for GMP Assurance
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Perform Visual Inspection of Vials Using Qualified Lighting Conditions

More about GMP Tips :

  • Do Not Leave Batch Records in Uncontrolled Office Areas
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas
  • Review Equipment Logbooks for Completeness During GMP Audits
  • Verify Integrity of Tamper-Evident Seals During Packaging
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Use Damaged Sieves or Mesh During Granulation in GMP
  • Conduct Alarm Challenge Tests to Validate Critical GMP System Responses
  • Never Use Photocopies as Originals for GMP Quality Documents
  • Do Not Allow Incomplete Documentation During GMP Batch Record Review
  • Do Not Ignore Elevated Noise Levels in GMP Classified Areas
  • Never Discard Rejected Materials in General Trash Bins
  • Maintain Temperature Logs for Cold Chain Pharmaceutical Products
  • Use Material Transfer Notes (MTNs) When Moving Raw Materials
  • Implement Controlled Access to Data Entry Terminals in GMP Areas

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme